Skip to main content

Table 1 Retention of ADEPT asthma subjects in study

From: Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

 

Number of subjects

% of number of subjects at baseline

Baseline

Month 3

Month 6

Month 12

Baseline

Month 3

Month 6

Month 12

Mild

52

48

47

45

100 %

92 %

90 %

87 %

Moderate

55

50

50

49

100 %

91 %

91 %

89 %

Severe

51

48

47

47

100 %

94 %

92 %

92 %

Total

158

146

144

141

100 %

92 %

91 %

89 %